AxoGen

About:

AxoGen is a biotech company developing treatment options for the reconstruction and repair of peripheral nerve injuries.

Website: http://www.axogeninc.com

Twitter/X: AxoGen

Top Investors: Cardinal Partners, DeNovo Ventures, Accuitive Medical Ventures, Springboard Capital, PDL Biopharma

Description:

AxoGen, Inc. engages in the development of treatment options for the repair of peripheral nerve injuries. It offers AVANCE Nerve Graft, a human allograft nerve that is used for the repair, replacement, and reconstruction of damaged peripheral nerves. The company accepts orders through phone, fax, or email. It serves surgeons. AxoGen has a strategic tissue recovery partnership with American Tissue Services Foundation (ATSF). The company was founded in 2002 and is based in Alachua, Florida.